Pharmaceutical firms stash cash as outlook stays gloomy

Published: 2012-04-26 06:58:00

Updated: 2012-04-26 06:58:00

Domestic pharmaceutical firms are holding sufficient amounts of cash – an indication that they are growing more pessimistic over the outlook for future economic and profits growth, data showed Monday.

Yakup.com, a pharmaceutical information company, said that the average current ratio of 110 d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK